Use of Coraxan in Patients with Cardiac and Pulmonary Pathology
Article Metrics
Abstract Views
239
PDF Downloads
116
- Authors
-
-
Jalilova Umida Djumaevna
Assistant, department of internal diseases, Bukhara State Medical Institute
-
- Keywords:
- Coraxan coronary heart disease blood pressure arterial hypertension chronic obstructive pulmonary disease heart rate physical activity
- Abstract
-
the article studied the effectiveness of the drug Coraxan in the complex therapy of patients with coronary heart disease (CHD) and arterial hypertension (AH) in combination with chronic obstructive pulmonary disease (COPD). The use of Coraxan in the treatment of patients with concomitant cardiopulmonary pathology leads to a significant decrease in blood pressure (BP) and heart rate (HR), and a decrease in angina attacks. Coraxan increases exercise tolerance (PE).
How to Cite
Djumaevna, J. U. (2024). Use of Coraxan in Patients with Cardiac and Pulmonary Pathology. Innovative Multidisciplinary Journal of Applied Technology, 2(4), 124-125. https://www.multijournals.org/index.php/innovative/article/view/918